Examples of using Response and tolerability in English and their translations into Swedish
{-}
- 
                        Medicine
                    
- 
                        Colloquial
                    
- 
                        Official
                    
- 
                        Ecclesiastic
                    
- 
                        Ecclesiastic
                    
- 
                        Official/political
                    
- 
                        Computer
                    
- 
                        Programming
                    
- 
                        Political
                    
Dose escalation should be based upon clinical response and tolerability.
Based on individual patient response and tolerability, the dosage may be increased to 300 mg per day after 1 week.
The dose may be increased to 80 mg daily, according to the response and tolerability.
Depending upon the clinical response and tolerability, the daily dose can be increased up to 1,500 mg twice daily.
Dose should be individualised according to the patient's response and tolerability.
Additionally, patient response and tolerability should be carefully monitored and  dose should be adapted accordingly.
The dose may be increased to 6 mg once daily based on clinical response and tolerability.
Based on individual patient response and tolerability, the dose may be adjusted in the dose range of 50 mg/day to 200 mg/day.
Dose increase or reduction is recommended based on patient response and tolerability.
Depending upon individual clinical response and tolerability, the dose may be increased
The dose can be increased to 10 mg twice daily based on individual clinical response and tolerability.
Depending on the clinical response and tolerability in the individual patient, the dose can be increased to 10 mg twice daily.
Dosing intervals should be modified according to clinical response and tolerability see sections 4.2 and  4.4.
Depending on the patient's response and tolerability for Intuniv the recommended maintenance dose range is 0.05-0.12 mg/kg/day.
moderate hepatic impairment should be based on clinical response and tolerability.
Based on drug exposure, pharmacodynamic response and tolerability, a lower dose of Pegasys is not needed in the geriatric patient see section 4.2.
according to the individual patient response and tolerability.
Depending upon individual clinical response and tolerability at a dose of 8 mg/day,
then adjust the dose according to your response and tolerability.
If concomitant use is warranted, patient response and tolerability should be monitored and  dose adjustments made if required see section 4.2.
In populations where the dose may be increased to 8 mg once daily, the dose increase should be preceded by an evaluation of the individual response and tolerability.
patient response and tolerability should be monitored and  dose should be adapted accordingly see section 4.4.
Consideration may be given to lowering the dose to 12.5mg in patients experiencing severe gastrointestinal adverse events depending upon the response and tolerability of individual patients.
According to clinical response and tolerability, after a minimum of 2 days the dose may be increased by 200 mg/day,
monitoring for clinical response and tolerability.
Depending on response and tolerability, the maintenance dose can be further increased by 50 mg twice a day every week, to a maximum recommended daily dose of 400 mg 200 mg twice a day.
During concomitant administration of a moderate CYP3A4 inhibitor, a dose increase to 8 mg should be preceded by an evaluation of the individual response and tolerability see sections 4.4 and  4.5.
Depending on response and tolerability, Vimpat 150 mg tablets may be taken twice a day during the third week
for the first 2 to 4 weeks of therapy depending on the patient's response and tolerability.
Based on individual patient response and tolerability, the dosage may be increased to 300 mg per day after an interval of 3 to 7 days,